Deep Medicine (NASDAQ:DMAQ) announced this afternoon that its shareholders approved its combination with golf simulator company TruGolf during a special meeting on January 19.
At the meeting, holders of 3,952,979 shares of DMAQ’s Class A common stock were present, constituting a quorum. The deal was overwhelmingly approved as holders of 3,933,438 shares voted in favor of the proposal, while holders of 18,838 shares pushed back against the combination.
In connection with the vote, shareholders of 378,744 DMAQ’s public shares opted to redeem their shares. DMAQ shareholders have redeemed an aggregate of 98.5% of the trust thus far (including prior votes), leaving the SPAC with $2,254,230 and 196,020 shares remaining.
The parties did not provide a timeline for the closing of the deal, but expect to complete it upon satisfaction or waiver of all the closing conditions, including approval to list on The Nasdaq. Upon closing, the combined company is expected to trade on the Nasdaq under the symbol “TRUG”.
The SPAC also has a minimum cash condition of at least $10 million, This amount is calculated after accounting for any redemptions and payment of amounts owed to DMAQ’s sponsor and its affiliates but before settling any unpaid expenses or liabilities, with a cap of $1.6 million.
Deep Medicine announced its $125 million deal with TruGolf in April 2023. It previously planned to combine with Chinese carmaker Chijet, but the deal was terminated in September 2022. Centerville, Utah-based TruGolf manufactures advanced golf simulators and launch monitors for both home entertainment and commercial uses.
At the SPAC of Dawn This week has been partially defined by market reactions to the core PPI inflation numbers that came out yesterday, but today’s session will receive fresh inputs on US retail, manufacturing and industrial production figures. SPACs also have to contend with public market reactions to new issuance that has not been...
Viking Acquisition Corp. I (NASDAQ:VACIU) has filed for a $200 million SPAC with strong terms led by international Deutsche Bank alumni. We are only halfway through the month of August, but teams have already filed S-1s for 12 new SPACs, matching July’s total. Cohen & Company has largely been the engine for this surge as...
Bleichroeder I (NASDAQ:BACQ) has entered into a definitive agreement to combine with defense contractor Merlin Labs at a pro forma enterprise value of $1 billion. Merlin is developing the technology for autonomously piloting aircraft in defense and civil applications. The combined company is expected to trade on the Nasdaq once the deal is completed in...
At the SPAC of Dawn It is only halfway through the month of August, but teams have already filed S-1s for 12 new SPACs, matching the total for all of July. Underwriter Cohen & Company has been responsible for half of this flow and four of its flock were rolled out just this week. This...
Tailwind 2.0 (NASDAQ:TDWDU) has filed for a $150 million SPAC to turn over a new leaf in its ongoing SPAC series. If the naming convention around Tailwind 2.0 seems strange, it is not without purpose. This is neither the second nor the third Tailwind SPAC. It is technically the fourth. The first Tailwind SPAC had...